PHP
RVTY icon

Parkman Healthcare Partners’s Revvity RVTY Stock Holding History

Parkman Healthcare Partners’s Portfolio RVTY Stock Details RVTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-157,196
Closed -$15.2M – 100
2025
Q2 		$15.2M Buy
157,196
+17,639
+13% +$1.66M 1.75% 19
2025
Q1 		$14.8M Buy
+139,557
New +$16.1M 1.75% 21

Other funds holding RVTY

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parkman Healthcare Partners's RVTY Position: Q3 2025 in Review

Parkman Healthcare Partners sold out of Revvity (RVTY) in Q3 2025, closing a stake of 157,196 shares — an estimated $15.2M sold.

Parkman Healthcare Partners first reported a position in RVTY in Q1 2025 and held it in 2 quarters. The position peaked at $15.2M in Q2 2025. 523 funds tracked by Wall St. Rank hold RVTY as of Q3 2025.

  • Parkman Healthcare Partners reported no remaining Revvity position as of Q3 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 157,196 Revvity shares in Q3 2025, an estimated $15.2M.
  • Parkman Healthcare Partners first reported a position in Revvity in Q1 2025 and held it in 2 quarters.
  • Parkman Healthcare Partners's Revvity position peaked at $15.2M in Q2 2025.
  • 523 funds tracked by Wall St. Rank held Revvity as of Q3 2025.

Based on Parkman Healthcare Partners's 13F filing for Q3 2025, filed 14 Nov 2025.